Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
about
Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant BacteriaUsing interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusCurrent ciprofloxacin usage in children hospitalized in a referral hospital in ParisPredictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infectionsSpontaneous bacterial peritonitis: a therapeutic update.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Imaging Findings in Two Cases of Fluoroquinolone-Induced Achilles TendinopathyPseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma.Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition in roommate contacts of patients colonized or infected with MRSA in an acute-care hospital.Screening the Drug Resistance Property Among Aerobic Pathogenic Microorganisms of Dental Caries in North-Western Indian Population: A Preliminary Study.Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum beta-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study.Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes.Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients.
P2860
Q26741585-7A603E70-6679-4F37-8A16-11EE267CC442Q34680578-8B60C1F6-516B-416E-B31B-41D7E1BB6753Q34741643-1B70B712-4828-44A4-9C91-FDBB740F167FQ35598469-1EB1753A-5810-4B22-B4BF-818E6BCFB1C7Q36441498-D4A82D50-9746-4DBF-8BBE-99E599573A41Q36718474-524932E3-E51F-47D6-946C-225F749955C0Q36964530-6898355B-DD3B-4F40-97C3-65103FCDC866Q37643058-050275C3-0659-4F15-A384-BC931BE88FF8Q38427273-87550CD0-B8CF-441D-A2E3-2DFE735164B3Q40335974-F3409C51-0E68-4237-936D-28BCFCCE226FQ40779607-034D5614-6062-456F-9A8D-F3473C9789C1Q42662040-C7C378F9-92A0-4AA3-ACEF-42B2B84E6052Q43247975-7AEF58E0-F40E-46EC-9963-69666238D2F1Q43792373-B0A118DD-2EF5-47C4-904D-83823954A045Q46510293-8D979BFE-FC85-4F18-88DE-4591FA05C82CQ46906475-3F1B5C86-CD02-4545-8B0F-5C4D30269C0DQ46943794-FD676653-4795-4789-B510-1402BA9895C8Q51547630-1939B1FB-346D-4B9E-AB17-7FBE23A8D9E8Q54446069-D99A9572-1D02-4024-81AD-96D43CB3C975
P2860
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@ast
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@en
type
label
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@ast
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@en
prefLabel
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@ast
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@en
P2093
P2860
P356
P1476
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
@en
P2093
Christopher K Johnson
Conan MacDougall
J Patrick Powell
Michael B Edmond
Ron E Polk
Spencer E Harpe
P2860
P304
P356
10.3201/EID1108.050116
P577
2005-08-01T00:00:00Z